RECORDATI RARE DISEASES INC. ACQUIRES NORTH AMERICAN MARKETING RIGHTS TO CYSTADANE® (BETAINE ANHYDROUS FOR ORAL SOLUTION) 04/13/2017 RECORDATI: ALBERTO RECORDATI APPOINTED CHAIRMAN; ANDREA RECORDATI APPOINTED VICE CHAIRMAN AND CHIEF EXECUTIVE OFFICER 08/16/2016 RECORDATI ANNOUNCES THAT ITS CHAIRMAN AND CEO GIOVANNI RECORDATI PASSED AWAY 08/16/2016 Pagination First page « First Previous page ‹ Previous … Page 11 Page 12 Page 13 Current page 14
RECORDATI RARE DISEASES INC. ACQUIRES NORTH AMERICAN MARKETING RIGHTS TO CYSTADANE® (BETAINE ANHYDROUS FOR ORAL SOLUTION) 04/13/2017
RECORDATI: ALBERTO RECORDATI APPOINTED CHAIRMAN; ANDREA RECORDATI APPOINTED VICE CHAIRMAN AND CHIEF EXECUTIVE OFFICER 08/16/2016
